RecallRadar

FDA Drug recall D-0257-2015

Amlodipine Besylate Tablets, USP 10 mg, Rx Only, 90 Tablets per bottle, Manufactured by: Cadila Healthcare Ltd

On 2014-12-03 the FDA classified a Class III recall of Amlodipine Besylate Tablets, USP 10 mg, Rx Only, 90 Tablets per bottle, Manufactured by: Cadila Healthcare Ltd by Zydus Pharmaceuticals Usa, citing discoloration: Brown spots were noted embedded in Amlodipine Besylate Tablets, 10 mg, Lot # MP4344.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0257-2015
ClassificationClass III
Statusterminated
Initiated2014-10-01
Published2014-12-03
Last updated2026-09-13 11:51 UTC
CompanyZydus Pharmaceuticals Usa
DistributionUS

Product

Amlodipine Besylate Tablets, USP 10 mg, Rx Only, 90 Tablets per bottle, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534, NDC 68382-123-16

Reason

Discoloration: Brown spots were noted embedded in Amlodipine Besylate Tablets, 10 mg, Lot # MP4344.

Identifiers

ndc68382-121-01
ndc68382-121-05
ndc68382-121-16
ndc68382-121-77
ndc68382-122-16
ndc68382-122-01
ndc68382-122-05
ndc68382-122-77
ndc68382-123-16
ndc68382-123-01
ndc68382-123-05
ndc68382-123-77
code_infoLot #: MP4344, Exp 04/2016

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0257-2015%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.